The bill encourages the Tennessee Department of Revenue to explore the idea of allowing franchise and excise tax credits to be transferable to other individuals or businesses. Currently, these credits can only be used by the entities they are issued to. If the study is conducted, the department must report its findings to legislative committees by January 1, 2026.
Supporters of the bill argue that making tax credits transferable could stimulate economic growth by allowing more businesses to benefit from these credits. They believe this flexibility could encourage investment and innovation in Tennessee, ultimately benefiting the state's economy.
Critics might argue that allowing the transfer of tax credits could lead to misuse or exploitation of the system, potentially reducing state revenue. They may also express concerns that the focus on tax credits could divert attention from more comprehensive tax reform and equitable tax policy.
The bill SB0430 proposes a study on the economic impact of making franchise and excise tax credits transferable. The sponsor, Shane Reeves, has personal financial interests primarily in the healthcare sector through his role as CEO of Twelve Stone Health Partners and as a pharmacy owner. However, these interests do not directly intersect with the banking, securities, or consumer credit sectors that the bill addresses. Since the bill focuses on tax credits rather than healthcare or pharmacy operations, the potential for personal financial gain from this legislation appears minimal. Additionally, there are no documented investments or business operations that would benefit from changes to tax credit transferability, further reducing the risk of conflict.
Unlike federal analysis based on campaign donations, state analysis examines legislators' personal financial interests — their jobs, businesses, and investments.
| Type | Description | Industry | Source |
|---|---|---|---|
| Employer | TWELVE STONE HEALTH PARTNERS | — | TN Ethics Commission |
| Business Owner | TWELVE STONE HEALTH PARTNERS CEO from Jan 2016 to Apr 2025 | — | TN Ethics Commission |
| Asset | 529 (AMERICAN FUNDS) | — | TN Ethics Commission |
| Occupation | Pharmacology, OWN A PHARMACY | — | TN Ethics Commission |
| Asset | Leadership PAC: REEVES FAMILY PAC | — | TN Ethics Commission |
About This Analysis
This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the Tennessee General Assembly. Conflict analysis examines the sponsor's personal financial interests for potential overlaps with the bill's subject matter.
TN SB0430